Treatment of Major Depressive Disorder With Psychotic Features.
Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of risperidone monotherapy
in the treatment of psychotic depression. We hypothesize that risperidone is as equally as
effective as haloperidol plus sertraline for depression with psychotic features